$60.0M in 2Q25 Total Product Revenue
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025
Seeking Alpha / 4 hours ago 1 Views
Seeking Alpha / 4 hours ago 1 Views
$60.0M in 2Q25 Total Product Revenue
Comments